Molecular and epigenetic features of melanomas and tumor immune microenvironment linked to durable remission to ipilimumab-based immunotherapy in metastatic patients.
Teofila SeremetAlexander KochYanina JansenMax SchreuerSofie WilgenhofVéronique Del MarmolDanielle LiènardKris ThielemansKelly SchatsMark KockxWim Van CriekingePierre G CoulieTim De MeyerNicolas van BarenBart NeynsPublished in: Journal of translational medicine (2016)
Combined analyses of melanoma metastases with IHC, gene expression and methylation profiling can potentially identify durable responders to Ipi-based immunotherapy.